Prot#747-302: A Phase 3b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cirrhosis

Project: Research project

Project Details

StatusFinished
Effective start/end date10/26/1510/26/20

Funding

  • Intercept Pharmaceuticals, Inc. (747-302)